LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 106 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $588 | +27.3% | 242 | 0.0% | 0.00% | – |
Q4 2022 | $462 | -53.8% | 242 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 242 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 242 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 242 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 242 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 242 | +70.4% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 142 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | +100.0% | 142 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | -50.0% | 142 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 142 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | -33.3% | 142 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $3,000 | – | 142 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $71,084,000 | 100.00% |
Artal Group S.A. | 57,517,977 | $946,170,000 | 16.53% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $587,000 | 1.74% |
SECTOR GAMMA AS | 622,655 | $10,243,000 | 1.49% |
NEA Management Company, LLC | 2,382,286 | $39,189,000 | 1.43% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 606,410 | $9,975,000 | 0.68% |
MOODY ALDRICH PARTNERS LLC | 30,930 | $509,000 | 0.64% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 499,200 | $8,212,000 | 0.56% |
USS Investment Management Ltd | 3,507,900 | $57,705,000 | 0.54% |
Rock Springs Capital Management LP | 393,500 | $6,473,000 | 0.33% |